126 related articles for article (PubMed ID: 32540764)
1. Folic acid modified gold nanoparticle for targeted delivery of Sorafenib tosylate towards the treatment of diabetic retinopathy.
Dave V; Sharma R; Gupta C; Sur S
Colloids Surf B Biointerfaces; 2020 Oct; 194():111151. PubMed ID: 32540764
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats.
Dong Y; Wan G; Yan P; Qian C; Li F; Peng G
J Photochem Photobiol B; 2019 Jun; 195():51-57. PubMed ID: 31082734
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.
Wang J; Tan J; Luo J; Huang P; Zhou W; Chen L; Long L; Zhang LM; Zhu B; Yang L; Deng DY
J Nanobiotechnology; 2017 Mar; 15(1):18. PubMed ID: 28249594
[TBL] [Abstract][Full Text] [Related]
4. Folic acid-cysteamine modified gold nanoparticle as a nanoprobe for targeted computed tomography imaging of cancer cells.
Khademi S; Sarkar S; Shakeri-Zadeh A; Attaran N; Kharrazi S; Ay MR; Ghadiri H
Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():182-193. PubMed ID: 29752088
[TBL] [Abstract][Full Text] [Related]
5. Subconjunctival Delivery of Sorafenib-Tosylate-Loaded Cubosomes for Facilitated Diabetic Retinopathy Treatment: Formulation Development, Evaluation, Pharmacokinetic and Pharmacodynamic (PKPD) Studies.
Madhusudhan S; Gupta NV; Rahamathulla M; Chidambaram SB; Osmani RAM; Ghazwani M; Ahmed MM; Farhana SA; Sarhan MY; Tousif AH
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896180
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cytotoxic activity of docetaxel loaded gold nanoparticles for lung cancer drug delivery.
Thambiraj S; Shruthi S; Vijayalakshmi R; Ravi Shankaran D
Cancer Treat Res Commun; 2019; 21():100157. PubMed ID: 31310876
[TBL] [Abstract][Full Text] [Related]
7. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
8. PEGylated polyethylenimine-entrapped gold nanoparticles modified with folic acid for targeted tumor CT imaging.
Zhou B; Yang J; Peng C; Zhu J; Tang Y; Zhu X; Shen M; Zhang G; Shi X
Colloids Surf B Biointerfaces; 2016 Apr; 140():489-496. PubMed ID: 26812636
[TBL] [Abstract][Full Text] [Related]
9. Green synthesis of pullulan stabilized gold nanoparticles for cancer targeted drug delivery.
Ganeshkumar M; Ponrasu T; Raja MD; Subamekala MK; Suguna L
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Sep; 130():64-71. PubMed ID: 24762575
[TBL] [Abstract][Full Text] [Related]
10. New organic/inorganic nanohybrids of targeted pullulan derivative/gold nanoparticles for effective drug delivery systems.
Laksee S; Sansanaphongpricha K; Puthong S; Sangphech N; Palaga T; Muangsin N
Int J Biol Macromol; 2020 Nov; 162():561-577. PubMed ID: 32553955
[TBL] [Abstract][Full Text] [Related]
11. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
[TBL] [Abstract][Full Text] [Related]
12. "Gold nanoparticles composite-folic acid conjugated graphene oxide nanohybrids" for targeted chemo-thermal cancer ablation: In vitro screening and in vivo studies.
Chauhan G; Chopra V; Tyagi A; Rath G; Sharma RK; Goyal AK
Eur J Pharm Sci; 2017 Jan; 96():351-361. PubMed ID: 27721039
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid coating of gold nanoparticles for intraocular drug delivery: Evaluation of the surface properties and effect on their distribution.
Apaolaza PS; Busch M; Asin-Prieto E; Peynshaert K; Rathod R; Remaut K; Dünker N; Göpferich A
Exp Eye Res; 2020 Sep; 198():108151. PubMed ID: 32721426
[TBL] [Abstract][Full Text] [Related]
14. Investigating the effect of near infrared photo thermal therapy folic acid conjugated gold nano shell on melanoma cancer cell line A375.
Majidi FS; Mohammadi E; Mehravi B; Nouri S; Ashtari K; Neshasteh-Riz A
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2161-2170. PubMed ID: 31159585
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery.
Alexander CM; Hamner KL; Maye MM; Dabrowiak JC
Bioconjug Chem; 2014 Jul; 25(7):1261-71. PubMed ID: 24911830
[TBL] [Abstract][Full Text] [Related]
16. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery.
Malekmohammadi S; Hadadzadeh H; Farrokhpour H; Amirghofran Z
Soft Matter; 2018 Mar; 14(12):2400-2410. PubMed ID: 29512668
[TBL] [Abstract][Full Text] [Related]
17. One-step preparation of gold nanovectors using folate modified polyethylenimine and their use in target-specific gene transfection.
Li Z; Liu Y; Huang X; Hu C; Wang H; Yuan L; Brash JL; Chen H
Colloids Surf B Biointerfaces; 2019 May; 177():306-312. PubMed ID: 30771582
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery.
Nie L; Sun S; Sun M; Zhou Q; Zhang Z; Zheng L; Wang L
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658190
[TBL] [Abstract][Full Text] [Related]
19. Folic acid-modified methotrexate-conjugated gold nanoparticles as nano-sized trojans for drug delivery to folate receptor-positive cancer cells.
Yücel O; Şengelen A; Emik S; Önay-Uçar E; Arda N; Gürdağ G
Nanotechnology; 2020 Aug; 31(35):355101. PubMed ID: 32413875
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery.
Rahme K; Guo J; Holmes JD; O'Driscoll CM
Colloids Surf B Biointerfaces; 2015 Nov; 135():604-612. PubMed ID: 26322474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]